MEDICALSYSTEM(SZ:300439) Xin Lang Cai Jing·2025-10-31 05:34Core Viewpoint - Meikang Bio's stock price has shown slight fluctuations, with a current market capitalization of 3.997 billion yuan, reflecting a mixed performance in recent trading periods [1] Financial Performance - For the period from January to September 2025, Meikang Bio reported a revenue of 1.136 billion yuan, representing a year-on-year decrease of 19.27% [2] - The net profit attributable to shareholders for the same period was 60.5338 million yuan, down 73.02% year-on-year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Meikang Bio was 23,900, a decrease of 6.95% from the previous period [2] - The average number of circulating shares per shareholder increased by 7.47% to 12,234 shares [2] Dividend Distribution - Since its A-share listing, Meikang Bio has distributed a total of 388 million yuan in dividends, with 143 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the fifth largest circulating shareholder among Meikang Bio's top ten was the Medical Device ETF (159883), which holds 1.4234 million shares as a new shareholder [3]